Sign In
Buy PRAX
$278.93
+20.85 (+8.08%)
At Close: Jun 03, 2026
Praxis Precision Medicines, Inc. (PRAX) Just Flashed Golden Cross Signal: Do You Buy?
11:18am, Friday, 05'th Jan 2024
After reaching an important support level, Praxis Precision Medicines, Inc. (PRAX) could be a good stock pick from a technical perspective. PRAX recently experienced a "golden cross" event, which saw
Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare Conference
04:00pm, Tuesday, 21'st Nov 2023
BOSTON, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for
Praxis Precision Medicines, Inc. (PRAX) Loses -32.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:19am, Tuesday, 14'th Nov 2023
The heavy selling pressure might have exhausted for Praxis Precision Medicines, Inc. (PRAX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement amon
New Strong Buy Stocks for October 11th
09:02am, Wednesday, 11'th Oct 2023
PBF, PRAX, CPRX, MFA and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2023.
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for
Praxis Precision Medicines to Present at the 2023 Jefferies Healthcare Conference
09:00am, Friday, 02'nd Jun 2023
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for
Praxis Precision Medicines to Present at the American Academy of Neurology 2023 Annual Meeting
08:00am, Wednesday, 19'th Apr 2023
BOSTON, April 19, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies fo
3 Hot Penny Stocks To Watch In The Stock Market Today
03:24pm, Monday, 17'th Apr 2023
Penny stocks to watch this week. The post 3 Hot Penny Stocks To Watch In The Stock Market Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Praxis Precision Medicines to Present at 22nd Annual Needham Virtual Healthcare Conference
09:00am, Thursday, 06'th Apr 2023
BOSTON, April 06, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies fo
Praxis Precision Medicines to Present at Upcoming Investor Conferences
04:05pm, Friday, 03'rd Mar 2023
BOSTON, March 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies fo
Praxis: Shaking The Dust Off Calcium Channel Blockers For Essential Tremor
02:26am, Friday, 03'rd Mar 2023
Praxis Precision Medicines' ulixacaltamide (PRAX-944) is a potent and selective small molecule T-type Ca2+ channel blocker being developed for the potential treatment of essential tremor. ET is a comm
Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting
04:05pm, Monday, 28'th Nov 2022
BOSTON, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for
Praxis Precision Medicines to Present at Upcoming Investor Conferences
09:00am, Monday, 07'th Nov 2022
BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
09:00am, Wednesday, 21'st Sep 2022
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies fo
Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
04:05pm, Wednesday, 07'th Sep 2022
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies fo
